Table 1 Median (IQR) of various parameters for control and NIDDM subjects with and without retinopathy.
From: Telomere mean length in patients with diabetic retinopathy
Parametrs | Control (n = 36) | NDR (n = 27) | NPDR (n = 45) | PDR (n = 13) |
|---|---|---|---|---|
Age (yrs) | 45 (38.5–51.75) | 52 (46–63) | 55 (46.5–60.5) | 51.50 (45.50–58.75) |
Hb | 12.48 (11.40 13.73) | 12.7(11.2–14.4) | 13.2 (11.45–14.30) | 12.05 (11.13–13.75)0.712*, 0.009** |
HbA1c | 4.80 (4.3–5.2) | 6.72 (6.29 8.15) | 6.90 (6.38–7.55) | 6.95 (6.38–7.58) −695*, 0.012** |
FBS | 92.25 (83.52–97.9) | 148.2 (129–189) | 149.8 (110.75–184.75) | 137.05 (95.64–177.22) |
TC | 165.5 (151–187.5) | 175 (129.4–205) | 174.6 (143.4–192.22) | 166.55 (128.8–247.72) |
TG | 139.5(100–155.5) | 112(80.2–138.2) | 101.6 (80.29–152.6) | 121.05 (85.52–195.25) |
HDL | 42.15 (38.35–46) 0.353*, 0.035** | 45 (35.6–52) | 45.3 (39.35–55.38) | 40.62 (38.16–48.71) |
LDL | 91.8 (86.3–109.5) | 108 (67.84–132.6) | 95.9 (74.16–120.56) | 94.69 (69.81–157.86) |
VLDL | 27.9 (20–31.1) | 22.40 (16.04–27.64) | 20.32 (16.06–30.52) | 24.21 (17.10–39.05) |
BUN | 10 (9.65–12) | 17 (13–20) | 18 (14–24.5) | 22.50 (18–42.50) |
Creatinine | 0.96 (0.89–1.07) | 0.94 (0.80–1.11) | 1.17 (94–1.32) | 1.04 (0.95–1.55) |
TP | 7.15 (6.65–7.3) | 7.3 (6.68–7.58) | 7.3 (6.96–7.70) | 7.16 (6.77–7.63) |
FI | 10.12 (9.17–12.93) | 9.87 (7.49–12.49) 0.423*, 0.028** | 12.62 (9.17–19.24) | 12.82(9.73–16.19) |
IR | 2.47 (2.01–3.41) | 3.55 (2.71–6.53) | 4.18 (2.74–7.7) | 4.77 (2.29–6.55) |
SBP | 120 (116–130) | 130 (120–150) | 140 (120–155) | 135 (110–143.75) |
DBP | 80 (75–90) | 90 (80–90) | 90 (80–90) | 82.5 (75–90) |
